nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.0812	0.0953	CbGbCtD
Indinavir—SLCO1A2—Prednisolone—ankylosing spondylitis	0.0728	0.0855	CbGbCtD
Indinavir—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0713	0.0837	CbGbCtD
Indinavir—SLCO1A2—Prednisone—ankylosing spondylitis	0.0688	0.0807	CbGbCtD
Indinavir—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.0429	0.0504	CbGbCtD
Indinavir—ABCC1—Methotrexate—ankylosing spondylitis	0.0386	0.0454	CbGbCtD
Indinavir—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0357	0.0419	CbGbCtD
Indinavir—ABCC2—Dexamethasone—ankylosing spondylitis	0.0356	0.0418	CbGbCtD
Indinavir—SLCO1A2—Methotrexate—ankylosing spondylitis	0.0345	0.0405	CbGbCtD
Indinavir—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0326	0.0382	CbGbCtD
Indinavir—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0307	0.036	CbGbCtD
Indinavir—ABCC2—Methotrexate—ankylosing spondylitis	0.0286	0.0336	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0238	0.0279	CbGbCtD
Indinavir—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0238	0.0279	CbGbCtD
Indinavir—CYP2C19—Prednisone—ankylosing spondylitis	0.023	0.027	CbGbCtD
Indinavir—ABCB1—Betamethasone—ankylosing spondylitis	0.0199	0.0234	CbGbCtD
Indinavir—ABCB1—Prednisolone—ankylosing spondylitis	0.0197	0.0231	CbGbCtD
Indinavir—ABCB1—Prednisone—ankylosing spondylitis	0.0186	0.0218	CbGbCtD
Indinavir—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0184	0.0216	CbGbCtD
Indinavir—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0178	0.0209	CbGbCtD
Indinavir—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0144	0.0169	CbGbCtD
Indinavir—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0139	0.0163	CbGbCtD
Indinavir—CYP2C9—Dexamethasone—ankylosing spondylitis	0.012	0.014	CbGbCtD
Indinavir—CYP3A4—Betamethasone—ankylosing spondylitis	0.012	0.014	CbGbCtD
Indinavir—CYP3A4—Prednisolone—ankylosing spondylitis	0.0118	0.0138	CbGbCtD
Indinavir—ABCB1—Dexamethasone—ankylosing spondylitis	0.0116	0.0136	CbGbCtD
Indinavir—CYP3A4—Prednisone—ankylosing spondylitis	0.0111	0.0131	CbGbCtD
Indinavir—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0109	0.0128	CbGbCtD
Indinavir—ABCB1—Methotrexate—ankylosing spondylitis	0.00933	0.0109	CbGbCtD
Indinavir—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00695	0.00816	CbGbCtD
Indinavir—Myalgia—Triamcinolone—ankylosing spondylitis	0.000212	0.00143	CcSEcCtD
Indinavir—Pneumonia—Methotrexate—ankylosing spondylitis	0.000212	0.00143	CcSEcCtD
Indinavir—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000211	0.00143	CcSEcCtD
Indinavir—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000211	0.00143	CcSEcCtD
Indinavir—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000211	0.00142	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00021	0.00142	CcSEcCtD
Indinavir—Flushing—Prednisone—ankylosing spondylitis	0.00021	0.00142	CcSEcCtD
Indinavir—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00021	0.00142	CcSEcCtD
Indinavir—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00021	0.00142	CcSEcCtD
Indinavir—Discomfort—Triamcinolone—ankylosing spondylitis	0.000209	0.00142	CcSEcCtD
Indinavir—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000209	0.00141	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000209	0.00141	CcSEcCtD
Indinavir—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000207	0.0014	CcSEcCtD
Indinavir—Renal failure—Methotrexate—ankylosing spondylitis	0.000207	0.0014	CcSEcCtD
Indinavir—Angioedema—Dexamethasone—ankylosing spondylitis	0.000206	0.0014	CcSEcCtD
Indinavir—Angioedema—Betamethasone—ankylosing spondylitis	0.000206	0.0014	CcSEcCtD
Indinavir—Immune system disorder—Prednisone—ankylosing spondylitis	0.000204	0.00138	CcSEcCtD
Indinavir—Malaise—Dexamethasone—ankylosing spondylitis	0.000204	0.00138	CcSEcCtD
Indinavir—Malaise—Betamethasone—ankylosing spondylitis	0.000204	0.00138	CcSEcCtD
Indinavir—Oedema—Triamcinolone—ankylosing spondylitis	0.000203	0.00137	CcSEcCtD
Indinavir—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000203	0.00137	CcSEcCtD
Indinavir—Vertigo—Betamethasone—ankylosing spondylitis	0.000203	0.00137	CcSEcCtD
Indinavir—Vertigo—Dexamethasone—ankylosing spondylitis	0.000203	0.00137	CcSEcCtD
Indinavir—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000203	0.00137	CcSEcCtD
Indinavir—Syncope—Dexamethasone—ankylosing spondylitis	0.000203	0.00137	CcSEcCtD
Indinavir—Syncope—Betamethasone—ankylosing spondylitis	0.000203	0.00137	CcSEcCtD
Indinavir—Sweating—Methotrexate—ankylosing spondylitis	0.000202	0.00136	CcSEcCtD
Indinavir—Haematuria—Methotrexate—ankylosing spondylitis	0.000201	0.00136	CcSEcCtD
Indinavir—Shock—Triamcinolone—ankylosing spondylitis	0.0002	0.00135	CcSEcCtD
Indinavir—Insomnia—Prednisolone—ankylosing spondylitis	0.0002	0.00135	CcSEcCtD
Indinavir—Alopecia—Prednisone—ankylosing spondylitis	0.0002	0.00135	CcSEcCtD
Indinavir—Shock—Methylprednisolone—ankylosing spondylitis	0.000199	0.00135	CcSEcCtD
Indinavir—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000199	0.00134	CcSEcCtD
Indinavir—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000199	0.00134	CcSEcCtD
Indinavir—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000199	0.00134	CcSEcCtD
Indinavir—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000199	0.00134	CcSEcCtD
Indinavir—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000198	0.00134	CcSEcCtD
Indinavir—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000197	0.00133	CcSEcCtD
Indinavir—Malnutrition—Prednisone—ankylosing spondylitis	0.000197	0.00133	CcSEcCtD
Indinavir—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000196	0.00133	CcSEcCtD
Indinavir—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000196	0.00132	CcSEcCtD
Indinavir—Myalgia—Dexamethasone—ankylosing spondylitis	0.000192	0.0013	CcSEcCtD
Indinavir—Myalgia—Betamethasone—ankylosing spondylitis	0.000192	0.0013	CcSEcCtD
Indinavir—Anxiety—Betamethasone—ankylosing spondylitis	0.000192	0.0013	CcSEcCtD
Indinavir—Anxiety—Dexamethasone—ankylosing spondylitis	0.000192	0.0013	CcSEcCtD
Indinavir—Discomfort—Dexamethasone—ankylosing spondylitis	0.00019	0.00128	CcSEcCtD
Indinavir—Discomfort—Betamethasone—ankylosing spondylitis	0.00019	0.00128	CcSEcCtD
Indinavir—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00019	0.00128	CcSEcCtD
Indinavir—Pain—Prednisolone—ankylosing spondylitis	0.000189	0.00128	CcSEcCtD
Indinavir—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000189	0.00128	CcSEcCtD
Indinavir—Hepatitis—Methotrexate—ankylosing spondylitis	0.000189	0.00128	CcSEcCtD
Indinavir—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000187	0.00127	CcSEcCtD
Indinavir—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000187	0.00126	CcSEcCtD
Indinavir—Vision blurred—Prednisone—ankylosing spondylitis	0.000185	0.00125	CcSEcCtD
Indinavir—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000185	0.00125	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000185	0.00125	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000185	0.00125	CcSEcCtD
Indinavir—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000184	0.00125	CcSEcCtD
Indinavir—Oedema—Dexamethasone—ankylosing spondylitis	0.000184	0.00125	CcSEcCtD
Indinavir—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000184	0.00125	CcSEcCtD
Indinavir—Oedema—Betamethasone—ankylosing spondylitis	0.000184	0.00125	CcSEcCtD
Indinavir—Insomnia—Triamcinolone—ankylosing spondylitis	0.000184	0.00124	CcSEcCtD
Indinavir—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000183	0.00124	CcSEcCtD
Indinavir—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000183	0.00123	CcSEcCtD
Indinavir—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000182	0.00123	CcSEcCtD
Indinavir—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000182	0.00123	CcSEcCtD
Indinavir—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000182	0.00123	CcSEcCtD
Indinavir—Anaemia—Prednisone—ankylosing spondylitis	0.000182	0.00123	CcSEcCtD
Indinavir—Shock—Dexamethasone—ankylosing spondylitis	0.000181	0.00123	CcSEcCtD
Indinavir—Shock—Betamethasone—ankylosing spondylitis	0.000181	0.00123	CcSEcCtD
Indinavir—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000181	0.00122	CcSEcCtD
Indinavir—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000181	0.00122	CcSEcCtD
Indinavir—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000181	0.00122	CcSEcCtD
Indinavir—Agitation—Prednisone—ankylosing spondylitis	0.000181	0.00122	CcSEcCtD
Indinavir—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000181	0.00122	CcSEcCtD
Indinavir—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000181	0.00122	CcSEcCtD
Indinavir—Angioedema—Prednisone—ankylosing spondylitis	0.00018	0.00121	CcSEcCtD
Indinavir—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000179	0.00121	CcSEcCtD
Indinavir—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000179	0.00121	CcSEcCtD
Indinavir—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000178	0.00121	CcSEcCtD
Indinavir—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000178	0.0012	CcSEcCtD
Indinavir—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000178	0.0012	CcSEcCtD
Indinavir—Malaise—Prednisone—ankylosing spondylitis	0.000177	0.0012	CcSEcCtD
Indinavir—Vertigo—Prednisone—ankylosing spondylitis	0.000177	0.00119	CcSEcCtD
Indinavir—Syncope—Prednisone—ankylosing spondylitis	0.000176	0.00119	CcSEcCtD
Indinavir—Anorexia—Dexamethasone—ankylosing spondylitis	0.000176	0.00119	CcSEcCtD
Indinavir—Anorexia—Betamethasone—ankylosing spondylitis	0.000176	0.00119	CcSEcCtD
Indinavir—Urticaria—Prednisolone—ankylosing spondylitis	0.000176	0.00119	CcSEcCtD
Indinavir—Fatigue—Triamcinolone—ankylosing spondylitis	0.000175	0.00118	CcSEcCtD
Indinavir—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000175	0.00118	CcSEcCtD
Indinavir—Pain—Triamcinolone—ankylosing spondylitis	0.000174	0.00117	CcSEcCtD
Indinavir—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000173	0.00117	CcSEcCtD
Indinavir—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000171	0.00115	CcSEcCtD
Indinavir—Chills—Methotrexate—ankylosing spondylitis	0.000169	0.00115	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000168	0.00114	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000168	0.00114	CcSEcCtD
Indinavir—Arthralgia—Prednisone—ankylosing spondylitis	0.000167	0.00113	CcSEcCtD
Indinavir—Myalgia—Prednisone—ankylosing spondylitis	0.000167	0.00113	CcSEcCtD
Indinavir—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000167	0.00113	CcSEcCtD
Indinavir—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000167	0.00113	CcSEcCtD
Indinavir—Anxiety—Prednisone—ankylosing spondylitis	0.000167	0.00113	CcSEcCtD
Indinavir—Alopecia—Methotrexate—ankylosing spondylitis	0.000167	0.00113	CcSEcCtD
Indinavir—Insomnia—Betamethasone—ankylosing spondylitis	0.000167	0.00113	CcSEcCtD
Indinavir—Insomnia—Dexamethasone—ankylosing spondylitis	0.000167	0.00113	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000166	0.00112	CcSEcCtD
Indinavir—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000166	0.00112	CcSEcCtD
Indinavir—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000166	0.00112	CcSEcCtD
Indinavir—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000166	0.00112	CcSEcCtD
Indinavir—Discomfort—Prednisone—ankylosing spondylitis	0.000165	0.00112	CcSEcCtD
Indinavir—Malnutrition—Methotrexate—ankylosing spondylitis	0.000164	0.00111	CcSEcCtD
Indinavir—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000163	0.0011	CcSEcCtD
Indinavir—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000162	0.0011	CcSEcCtD
Indinavir—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000162	0.0011	CcSEcCtD
Indinavir—Urticaria—Triamcinolone—ankylosing spondylitis	0.000161	0.00109	CcSEcCtD
Indinavir—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000161	0.00109	CcSEcCtD
Indinavir—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000161	0.00109	CcSEcCtD
Indinavir—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000161	0.00109	CcSEcCtD
Indinavir—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000161	0.00109	CcSEcCtD
Indinavir—Oedema—Prednisone—ankylosing spondylitis	0.000161	0.00109	CcSEcCtD
Indinavir—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00016	0.00108	CcSEcCtD
Indinavir—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00016	0.00108	CcSEcCtD
Indinavir—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00016	0.00108	CcSEcCtD
Indinavir—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000159	0.00108	CcSEcCtD
Indinavir—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000159	0.00108	CcSEcCtD
Indinavir—Back pain—Methotrexate—ankylosing spondylitis	0.000159	0.00107	CcSEcCtD
Indinavir—Fatigue—Betamethasone—ankylosing spondylitis	0.000159	0.00107	CcSEcCtD
Indinavir—Fatigue—Dexamethasone—ankylosing spondylitis	0.000159	0.00107	CcSEcCtD
Indinavir—Shock—Prednisone—ankylosing spondylitis	0.000158	0.00107	CcSEcCtD
Indinavir—Pain—Betamethasone—ankylosing spondylitis	0.000158	0.00107	CcSEcCtD
Indinavir—Pain—Dexamethasone—ankylosing spondylitis	0.000158	0.00107	CcSEcCtD
Indinavir—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000157	0.00106	CcSEcCtD
Indinavir—Skin disorder—Prednisone—ankylosing spondylitis	0.000156	0.00105	CcSEcCtD
Indinavir—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000155	0.00105	CcSEcCtD
Indinavir—Vision blurred—Methotrexate—ankylosing spondylitis	0.000155	0.00105	CcSEcCtD
Indinavir—Anorexia—Prednisone—ankylosing spondylitis	0.000153	0.00103	CcSEcCtD
Indinavir—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000153	0.00103	CcSEcCtD
Indinavir—Anaemia—Methotrexate—ankylosing spondylitis	0.000152	0.00103	CcSEcCtD
Indinavir—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000152	0.00103	CcSEcCtD
Indinavir—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000152	0.00103	CcSEcCtD
Indinavir—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000151	0.00102	CcSEcCtD
Indinavir—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000151	0.00102	CcSEcCtD
Indinavir—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00015	0.00101	CcSEcCtD
Indinavir—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000149	0.00101	CcSEcCtD
Indinavir—Malaise—Methotrexate—ankylosing spondylitis	0.000148	0.001	CcSEcCtD
Indinavir—Vertigo—Methotrexate—ankylosing spondylitis	0.000148	0.000998	CcSEcCtD
Indinavir—Urticaria—Dexamethasone—ankylosing spondylitis	0.000146	0.00099	CcSEcCtD
Indinavir—Urticaria—Betamethasone—ankylosing spondylitis	0.000146	0.00099	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000146	0.000989	CcSEcCtD
Indinavir—Dizziness—Prednisolone—ankylosing spondylitis	0.000146	0.000988	CcSEcCtD
Indinavir—Asthenia—Triamcinolone—ankylosing spondylitis	0.000146	0.000985	CcSEcCtD
Indinavir—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000146	0.000985	CcSEcCtD
Indinavir—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000146	0.000985	CcSEcCtD
Indinavir—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000146	0.000985	CcSEcCtD
Indinavir—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000146	0.000985	CcSEcCtD
Indinavir—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000145	0.000983	CcSEcCtD
Indinavir—Insomnia—Prednisone—ankylosing spondylitis	0.000145	0.000982	CcSEcCtD
Indinavir—Paraesthesia—Prednisone—ankylosing spondylitis	0.000144	0.000974	CcSEcCtD
Indinavir—Pruritus—Triamcinolone—ankylosing spondylitis	0.000144	0.000972	CcSEcCtD
Indinavir—Cough—Methotrexate—ankylosing spondylitis	0.000143	0.00097	CcSEcCtD
Indinavir—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000143	0.000969	CcSEcCtD
Indinavir—Dyspepsia—Prednisone—ankylosing spondylitis	0.000141	0.000955	CcSEcCtD
Indinavir—Arthralgia—Methotrexate—ankylosing spondylitis	0.00014	0.000946	CcSEcCtD
Indinavir—Chest pain—Methotrexate—ankylosing spondylitis	0.00014	0.000946	CcSEcCtD
Indinavir—Myalgia—Methotrexate—ankylosing spondylitis	0.00014	0.000946	CcSEcCtD
Indinavir—Decreased appetite—Prednisone—ankylosing spondylitis	0.00014	0.000943	CcSEcCtD
Indinavir—Rash—Prednisolone—ankylosing spondylitis	0.000139	0.000942	CcSEcCtD
Indinavir—Dermatitis—Prednisolone—ankylosing spondylitis	0.000139	0.000941	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000139	0.00094	CcSEcCtD
Indinavir—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000139	0.000938	CcSEcCtD
Indinavir—Fatigue—Prednisone—ankylosing spondylitis	0.000138	0.000936	CcSEcCtD
Indinavir—Headache—Prednisolone—ankylosing spondylitis	0.000138	0.000936	CcSEcCtD
Indinavir—Discomfort—Methotrexate—ankylosing spondylitis	0.000138	0.000935	CcSEcCtD
Indinavir—Constipation—Prednisone—ankylosing spondylitis	0.000137	0.000928	CcSEcCtD
Indinavir—Dizziness—Triamcinolone—ankylosing spondylitis	0.000134	0.000908	CcSEcCtD
Indinavir—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000134	0.000907	CcSEcCtD
Indinavir—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000134	0.000906	CcSEcCtD
Indinavir—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000132	0.000894	CcSEcCtD
Indinavir—Asthenia—Dexamethasone—ankylosing spondylitis	0.000132	0.000894	CcSEcCtD
Indinavir—Asthenia—Betamethasone—ankylosing spondylitis	0.000132	0.000894	CcSEcCtD
Indinavir—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000132	0.000889	CcSEcCtD
Indinavir—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000131	0.000888	CcSEcCtD
Indinavir—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000131	0.000887	CcSEcCtD
Indinavir—Nausea—Prednisolone—ankylosing spondylitis	0.000131	0.000887	CcSEcCtD
Indinavir—Pruritus—Betamethasone—ankylosing spondylitis	0.00013	0.000882	CcSEcCtD
Indinavir—Pruritus—Dexamethasone—ankylosing spondylitis	0.00013	0.000882	CcSEcCtD
Indinavir—Skin disorder—Methotrexate—ankylosing spondylitis	0.00013	0.000881	CcSEcCtD
Indinavir—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00013	0.000877	CcSEcCtD
Indinavir—Vomiting—Triamcinolone—ankylosing spondylitis	0.000129	0.000873	CcSEcCtD
Indinavir—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000129	0.000871	CcSEcCtD
Indinavir—Rash—Triamcinolone—ankylosing spondylitis	0.000128	0.000866	CcSEcCtD
Indinavir—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000128	0.000865	CcSEcCtD
Indinavir—Anorexia—Methotrexate—ankylosing spondylitis	0.000128	0.000864	CcSEcCtD
Indinavir—Rash—Methylprednisolone—ankylosing spondylitis	0.000128	0.000864	CcSEcCtD
Indinavir—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000128	0.000863	CcSEcCtD
Indinavir—Urticaria—Prednisone—ankylosing spondylitis	0.000128	0.000862	CcSEcCtD
Indinavir—Headache—Triamcinolone—ankylosing spondylitis	0.000127	0.00086	CcSEcCtD
Indinavir—Headache—Methylprednisolone—ankylosing spondylitis	0.000127	0.000858	CcSEcCtD
Indinavir—Body temperature increased—Prednisone—ankylosing spondylitis	0.000127	0.000858	CcSEcCtD
Indinavir—Abdominal pain—Prednisone—ankylosing spondylitis	0.000127	0.000858	CcSEcCtD
Indinavir—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000126	0.000853	CcSEcCtD
Indinavir—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000126	0.000853	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000122	0.000826	CcSEcCtD
Indinavir—Dizziness—Dexamethasone—ankylosing spondylitis	0.000122	0.000824	CcSEcCtD
Indinavir—Dizziness—Betamethasone—ankylosing spondylitis	0.000122	0.000824	CcSEcCtD
Indinavir—Insomnia—Methotrexate—ankylosing spondylitis	0.000121	0.00082	CcSEcCtD
Indinavir—Nausea—Triamcinolone—ankylosing spondylitis	0.000121	0.000816	CcSEcCtD
Indinavir—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00012	0.000814	CcSEcCtD
Indinavir—Nausea—Methylprednisolone—ankylosing spondylitis	0.00012	0.000814	CcSEcCtD
Indinavir—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00012	0.000809	CcSEcCtD
Indinavir—Somnolence—Methotrexate—ankylosing spondylitis	0.000119	0.000806	CcSEcCtD
Indinavir—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000118	0.0008	CcSEcCtD
Indinavir—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000118	0.000798	CcSEcCtD
Indinavir—Vomiting—Betamethasone—ankylosing spondylitis	0.000117	0.000792	CcSEcCtD
Indinavir—Vomiting—Dexamethasone—ankylosing spondylitis	0.000117	0.000792	CcSEcCtD
Indinavir—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000117	0.000788	CcSEcCtD
Indinavir—Rash—Dexamethasone—ankylosing spondylitis	0.000116	0.000786	CcSEcCtD
Indinavir—Rash—Betamethasone—ankylosing spondylitis	0.000116	0.000786	CcSEcCtD
Indinavir—Dermatitis—Betamethasone—ankylosing spondylitis	0.000116	0.000785	CcSEcCtD
Indinavir—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000116	0.000785	CcSEcCtD
Indinavir—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000116	0.000783	CcSEcCtD
Indinavir—Fatigue—Methotrexate—ankylosing spondylitis	0.000116	0.000782	CcSEcCtD
Indinavir—Headache—Betamethasone—ankylosing spondylitis	0.000115	0.000781	CcSEcCtD
Indinavir—Headache—Dexamethasone—ankylosing spondylitis	0.000115	0.000781	CcSEcCtD
Indinavir—Asthenia—Prednisone—ankylosing spondylitis	0.000115	0.000779	CcSEcCtD
Indinavir—Pain—Methotrexate—ankylosing spondylitis	0.000115	0.000776	CcSEcCtD
Indinavir—Pruritus—Prednisone—ankylosing spondylitis	0.000114	0.000768	CcSEcCtD
Indinavir—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000111	0.000747	CcSEcCtD
Indinavir—Diarrhoea—Prednisone—ankylosing spondylitis	0.00011	0.000742	CcSEcCtD
Indinavir—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00011	0.000742	CcSEcCtD
Indinavir—Nausea—Betamethasone—ankylosing spondylitis	0.00011	0.00074	CcSEcCtD
Indinavir—Nausea—Dexamethasone—ankylosing spondylitis	0.00011	0.00074	CcSEcCtD
Indinavir—Urticaria—Methotrexate—ankylosing spondylitis	0.000107	0.00072	CcSEcCtD
Indinavir—Dizziness—Prednisone—ankylosing spondylitis	0.000106	0.000718	CcSEcCtD
Indinavir—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000106	0.000717	CcSEcCtD
Indinavir—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000106	0.000717	CcSEcCtD
Indinavir—Vomiting—Prednisone—ankylosing spondylitis	0.000102	0.00069	CcSEcCtD
Indinavir—Rash—Prednisone—ankylosing spondylitis	0.000101	0.000684	CcSEcCtD
Indinavir—Dermatitis—Prednisone—ankylosing spondylitis	0.000101	0.000684	CcSEcCtD
Indinavir—Headache—Prednisone—ankylosing spondylitis	0.000101	0.00068	CcSEcCtD
Indinavir—Hypersensitivity—Methotrexate—ankylosing spondylitis	9.89e-05	0.000668	CcSEcCtD
Indinavir—Asthenia—Methotrexate—ankylosing spondylitis	9.63e-05	0.000651	CcSEcCtD
Indinavir—Nausea—Prednisone—ankylosing spondylitis	9.54e-05	0.000645	CcSEcCtD
Indinavir—Pruritus—Methotrexate—ankylosing spondylitis	9.49e-05	0.000642	CcSEcCtD
Indinavir—Diarrhoea—Methotrexate—ankylosing spondylitis	9.18e-05	0.000621	CcSEcCtD
Indinavir—Dizziness—Methotrexate—ankylosing spondylitis	8.87e-05	0.0006	CcSEcCtD
Indinavir—Vomiting—Methotrexate—ankylosing spondylitis	8.53e-05	0.000577	CcSEcCtD
Indinavir—Rash—Methotrexate—ankylosing spondylitis	8.46e-05	0.000572	CcSEcCtD
Indinavir—Dermatitis—Methotrexate—ankylosing spondylitis	8.45e-05	0.000571	CcSEcCtD
Indinavir—Headache—Methotrexate—ankylosing spondylitis	8.41e-05	0.000568	CcSEcCtD
Indinavir—Nausea—Methotrexate—ankylosing spondylitis	7.97e-05	0.000539	CcSEcCtD
